Lv3
398 积分 2023-11-22 加入
A real-world pharmacovigilance study of Sacubitril\valsartan in older people: data mining of the FDA adverse event reporting system
1个月前
已完结
Serious Adverse Events of Inclisiran in Patients With Hypercholesterolemia, a Meta-Analysis of ORION Trials
2个月前
已完结
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
4个月前
已完结
Safety evaluation of bempedoic acid: A pharmacovigilance analysis using FDA adverse event reporting system data
4个月前
已完结
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study
4个月前
已完结
Mining of adverse event signals associated with inclisiran: a post-marketing analysis based on FAERS
5个月前
已完结
Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis
6个月前
已完结
Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database
6个月前
已完结
Adverse events associated with inclisiran: a real-world disproportionality analysis based on the FAERS database
6个月前
已完结
Analysis of Inclisiran in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and Sex-specific Subgroups
8个月前
已完结
皖公网安备34019202002308
